Unlimited Bio News

Unlimited Bio Showcases Synergistic Gene Therapy Approach at Vitalist Bay

11/05/2025 — Unlimited Bio at Vitalist Bay – YouTube

In a presentation at Vitalist Bay, Unlimited Bio CEO Ivan Morgunov and CTO Anna Vakhrusheva spotlighted its ambitious ambition: combining gene therapies to achieve synergistic gains in longevity. The video captures key insights into how the company is pushing beyond single-gene interventions toward integrated, multi-pathway strategies.

Highlights of the Presentation

  • Synergy Over Single Targets. Unlimited Bio emphasizes that combining therapies (e.g. VEGF, Follistatin, Klotho, BDNF) can produce more than additive effects by reinforcing multiple biological systems.
  • Strategic Development Stages. The team discussed early-stage plans to test combinations in preclinical settings, optimizing dosing and timing to maximize synergistic benefit while managing safety.
  • Integration with Lifestyle. The analogy was drawn to lifestyle interventions — diet, exercise, sleep — which already act across multiple pathways; gene therapy combinations are a technological extension of that principle.
  • Vision & Scaling. Unlimited Bio reinforced its long-term roadmap: evolving from monotherapies to stable, scalable gene-therapy cocktails that can be deployed in human populations.

“If we continue to treat aging as a single dimension, we will always fall short. True rejuvenation requires orchestration across systems.”

The Vitalist Bay showcase underscored Unlimited Bio’s role as a pioneer in the next generation of longevity biotechnology — combining ambition, engineering, and biological insight to push the frontier forward.